One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial
Sanjiv J. Shah*, Ted Feldman, Mark J. Ricciardi, Rami Kahwash, Scott Lilly, Sheldon Litwin, Chris D. Nielsen, Pim Van Der Harst, Elke Hoendermis, Martin Penicka, Jozef Bartunek, Peter S. Fail, David M. Kaye, Anthony Walton, Mark C. Petrie, Niki Walker, Anupam Basuray, Steven Yakubov, Scott L. Hummel, Stanley ChetcutiRhondalyn Forde-Mclean, Howard C. Herrmann, Daniel Burkhoff, Joseph M. Massaro, John G.F. Cleland, Laura Mauri
Dive into the research topics of 'One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial'. Together they form a unique fingerprint.